about
Lymph nodal metastases: diagnosis and treatmentEvaluation of 18F-fluorothymidine positron emission tomography ([18F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer.Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.Imaging biomarkers in prostate cancer: role of PET/CT and MRI.Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT.Imaging biomarkers in ovarian cancer: the role of ¹⁸F-FDG PET/CT.FDG-PET/CT predicts outcome in oropharingeal carcinoma patients undergoing intensity modulated radiation therapy with dose escalation to FDG-avid tumour volumes.[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective.PET guidance in prostate cancer radiotherapy: Quantitative imaging to predict response and guide treatment.11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer.Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis.PET imaging for lymph node dissection in prostate cancer.Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors.High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.[Multi-modality imaging: mycotic abscess of a pericardial patch].Frequency and significance of physiological versus pathological uptake of 68Ga-DOTATATE in the pancreas: validation with morphological imaging.Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by ¹⁸F-FDG PET/CT.Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia.Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT.Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer.The relationship between local recurrences and distant metastases in prostate cancer: can 11C-choline PET/CT contribute to understand the link?11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients.18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy.18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry.18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas.Radiation Treatment of Lymph Node Recurrence from Prostate Cancer: Is 11C-Choline PET/CT Predictive of Survival Outcomes?Sarcoidosis mimicking metastatic gynaecological malignancies: a diagnostic and therapeutic challenge?[11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.Incidental finding of parathyroid adenoma with 11C-choline PET/CT.Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression.Prostate cancer recurrence: can PSA guide imaging?[11C]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomyUnusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on 18F-FDG-PET/CT resembling an early recurrence of Hodgkin's LymphomaErdheim-Chester Disease[Non ST ergometric variables in the diabetic patient and their prognostic significance]FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patientsPrognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/mlPositron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients
P50
Q27002921-254D61A1-1519-42C7-A376-F6B63846BBACQ37418581-00D216C9-3F88-4A88-AF29-BABE8DB5487EQ38272919-7B9B9BE2-DBD0-4E70-9495-22CE33958057Q38321182-BFBE2746-B290-4DC8-B6A6-F492AAFCED2FQ38564109-834727CF-FEC4-4DFD-90FA-C0433F66DE71Q38727152-E7C179D1-2540-4524-92D5-8BC66975FB8DQ38729923-493A2F8E-AE1C-4081-AD9E-3076FE58F2A8Q38730170-9258FBB7-5DA2-4304-9D67-48124D9ABC02Q38808751-70B1FA7A-E2F8-49E3-A430-6E8EB72C5673Q38970106-43844405-006A-45B6-A727-44FFCDD678D4Q38970109-99E958A9-2C05-484F-90E9-BD1D803905AAQ38983526-2C90C379-1606-41FF-9B42-42B4B4FEFB24Q39771221-9379AF54-C484-4881-8D20-2012D4C30651Q43157155-6E38996C-748B-4398-92E2-9808B7B73935Q43653931-DAC88536-8E2B-49F4-A89B-C7A2B7068853Q43828417-170D2B55-C7C9-4157-84B5-2556FDC75A96Q43857757-C8E44D0C-4DC2-409A-B24F-5D3FE6FEA76EQ46725112-E84E4CEE-83C4-427D-BAB2-AD2DEC085780Q47886549-2D6B93AB-5C9F-4DE9-9DC8-3CF31C2C1A06Q48932198-2812B1E6-7EFB-4EBD-A264-FC21AD478BCBQ49908509-AEB42860-1B16-480D-B71F-583C303CD4DDQ49967864-74945813-55F3-4AE5-AEE4-FAA9D28203CDQ50073906-440F9200-1B6E-4FB0-826D-ED3F77C92D85Q50098421-871650D7-AF2F-4DCB-9C1F-89094BA5B86FQ50550439-D86933A7-779D-47B9-A48A-28E913C78137Q52990685-52450958-E389-4482-95F1-B88F6E737060Q53127130-53C2CF4B-8A99-47DE-B51D-7BF720A94B4DQ53132277-B4E1410C-929A-431B-8F6D-7AD833C1488CQ53160782-A7F229F8-838B-47AF-A862-66B2B02DDCFFQ53194256-E80F6971-EB74-4853-BAB4-2DBEA95FCE7CQ57780533-230F02FD-4572-4043-8FE5-2844F3A9C88EQ57780535-77DFDE8F-364E-4747-BD83-FCEFF1596EEFQ57780572-CC7B337F-6A82-44D8-A0AD-BED839DB5359Q57780660-F63749CE-717A-44AE-8C22-F3F315D6BC69Q57780665-3B0918EC-94AE-4719-9954-EA71DB922E17Q89017219-6DE3173C-1EE8-4DC1-9EC5-C2A00ADF80B7Q90679239-DB9DE5FC-12D3-440D-B0CA-F21BDE4ACC49Q90993157-8FEEC9B8-95D0-4DBA-80DD-F1D2194B0257Q91841348-F24BCFE3-0697-4B52-BA2B-E2B5C830021CQ92311503-B1638A6A-9F5F-4FF0-8B96-DD4B7610E3B5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paola Mapelli
@ast
Paola Mapelli
@en
Paola Mapelli
@es
Paola Mapelli
@nl
Paola Mapelli
@sl
type
label
Paola Mapelli
@ast
Paola Mapelli
@en
Paola Mapelli
@es
Paola Mapelli
@nl
Paola Mapelli
@sl
prefLabel
Paola Mapelli
@ast
Paola Mapelli
@en
Paola Mapelli
@es
Paola Mapelli
@nl
Paola Mapelli
@sl
P106
P21
P31
P496
0000-0002-8780-5690